Vertex Pharmaceuticals Inc
NASDAQ:VRTX

Watchlist Manager
Vertex Pharmaceuticals Inc Logo
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Watchlist
Price: 491.89 USD -0.55% Market Closed
Market Cap: 127B USD
Have any thoughts about
Vertex Pharmaceuticals Inc?
Write Note

Gross Margin
Vertex Pharmaceuticals Inc

86.1%
Current
88%
Average
63.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
86.1%
=
Gross Profit
9.2B
/
Revenue
10.6B

Gross Margin Across Competitors

Country US
Market Cap 126.8B USD
Gross Margin
86%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 300.2B USD
Gross Margin
67%
Country US
Market Cap 158.7B USD
Gross Margin
60%
Country US
Market Cap 115B USD
Gross Margin
78%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 137.3B AUD
Gross Margin
52%
Country US
Market Cap 88.3B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 34.1B EUR
Gross Margin
89%
Country US
Market Cap 33.6B USD
Gross Margin
85%

Profitability Report

View the profitability report to see the full profitability analysis for Vertex Pharmaceuticals Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
86.1%
=
Gross Profit
9.2B
/
Revenue
10.6B
What is the Gross Margin of Vertex Pharmaceuticals Inc?

Based on Vertex Pharmaceuticals Inc's most recent financial statements, the company has Gross Margin of 86.1%.